Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy - PubMed (original) (raw)

. 2010 Nov 1;19(21):4207-15.

doi: 10.1093/hmg/ddq339. Epub 2010 Aug 17.

Affiliations

• PMID: 20716577
• DOI: 10.1093/hmg/ddq339

Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy

Sara Menazza et al. Hum Mol Genet. 2010.

Abstract

Several studies documented the key role of oxidative stress and abnormal production of reactive oxygen species (ROS) in the pathophysiology of muscular dystrophies (MDs). The sources of ROS, however, are still controversial as well as their major molecular targets. This study investigated whether ROS produced in mitochondria by monoamine oxidase (MAO) contributes to MD pathogenesis. Pargyline, an MAO inhibitor, reduced ROS accumulation along with a beneficial effect on the dystrophic phenotype of Col6a1(-/-) mice, a model of Bethlem myopathy and Ullrich congenital MD, and mdx mice, a model of Duchenne MD. Based on our previous observations on oxidative damage of myofibrillar proteins in heart failure, we hypothesized that MAO-dependent ROS might impair contractile function in dystrophic muscles. Indeed, oxidation of myofibrillar proteins, as probed by formation of disulphide cross-bridges in tropomyosin, was detected in both Col6a1(-/-) and mdx muscles. Notably, pargyline significantly reduced myofiber apoptosis and ameliorated muscle strength in Col6a1(-/-) mice. This study demonstrates a novel and determinant role of MAO in MDs, adding evidence of the pivotal role of mitochondria and suggesting a therapeutic potential for MAO inhibition.

PubMed Disclaimer

Similar articles

• Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.
  Sorato E, Menazza S, Zulian A, Sabatelli P, Gualandi F, Merlini L, Bonaldo P, Canton M, Bernardi P, Di Lisa F. Sorato E, et al. Free Radic Biol Med. 2014 Oct;75:40-7. doi: 10.1016/j.freeradbiomed.2014.07.006. Epub 2014 Jul 10. Free Radic Biol Med. 2014. PMID: 25017965 Free PMC article.
• Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients.
  Vitiello L, Marabita M, Sorato E, Nogara L, Forestan G, Mouly V, Salviati L, Acosta M, Blaauw B, Canton M. Vitiello L, et al. Front Physiol. 2018 Aug 14;9:1087. doi: 10.3389/fphys.2018.01087. eCollection 2018. Front Physiol. 2018. PMID: 30154729 Free PMC article.
• Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice.
  Palma E, Tiepolo T, Angelin A, Sabatelli P, Maraldi NM, Basso E, Forte MA, Bernardi P, Bonaldo P. Palma E, et al. Hum Mol Genet. 2009 Jun 1;18(11):2024-31. doi: 10.1093/hmg/ddp126. Epub 2009 Mar 17. Hum Mol Genet. 2009. PMID: 19293339
• Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies.
  Bernardi P, Bonaldo P. Bernardi P, et al. Ann N Y Acad Sci. 2008 Dec;1147:303-11. doi: 10.1196/annals.1427.009. Ann N Y Acad Sci. 2008. PMID: 19076452 Review.
• Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.
  Terrill JR, Radley-Crabb HG, Iwasaki T, Lemckert FA, Arthur PG, Grounds MD. Terrill JR, et al. FEBS J. 2013 Sep;280(17):4149-64. doi: 10.1111/febs.12142. Epub 2013 Feb 15. FEBS J. 2013. PMID: 23332128 Review.

Cited by

• Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration.
  Grumati P, Coletto L, Sabatelli P, Cescon M, Angelin A, Bertaggia E, Blaauw B, Urciuolo A, Tiepolo T, Merlini L, Maraldi NM, Bernardi P, Sandri M, Bonaldo P. Grumati P, et al. Nat Med. 2010 Nov;16(11):1313-20. doi: 10.1038/nm.2247. Epub 2010 Oct 31. Nat Med. 2010. PMID: 21037586
• Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies.
  Mongirdienė A, Skrodenis L, Varoneckaitė L, Mierkytė G, Gerulis J. Mongirdienė A, et al. Biomedicines. 2022 Mar 3;10(3):602. doi: 10.3390/biomedicines10030602. Biomedicines. 2022. PMID: 35327404 Free PMC article. Review.
• Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.
  Aminzadeh MA, Rogers RG, Fournier M, Tobin RE, Guan X, Childers MK, Andres AM, Taylor DJ, Ibrahim A, Ding X, Torrente A, Goldhaber JM, Lewis M, Gottlieb RA, Victor RA, Marbán E. Aminzadeh MA, et al. Stem Cell Reports. 2018 Mar 13;10(3):942-955. doi: 10.1016/j.stemcr.2018.01.023. Epub 2018 Mar 1. Stem Cell Reports. 2018. PMID: 29478899 Free PMC article.
• Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.
  Hearn JM, Romero-Canelón I, Munro AF, Fu Y, Pizarro AM, Garnett MJ, McDermott U, Carragher NO, Sadler PJ. Hearn JM, et al. Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3800-5. doi: 10.1073/pnas.1500925112. Epub 2015 Jul 10. Proc Natl Acad Sci U S A. 2015. PMID: 26162681 Free PMC article.
• Decreased collagen VI in the tunica media of pulmonary vessels during exposure to hypoxia: a novel step in pulmonary arterial remodeling.
  Žaloudíková M, Eckhardt A, Vytášek R, Uhlík J, Novotný T, Bačáková L, Musílková J, Hampl V. Žaloudíková M, et al. Pulm Circ. 2019 Jul-Sep;9(3):2045894019860747. doi: 10.1177/2045894019860747. Pulm Circ. 2019. PMID: 31187694 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal